13F filer · CIK 93751 ↗

State Street

You are looking at Q1 2017. See the latest, Q2 2026 →

Reported value

$1.12T

+5.5% on the quarter before

Positions

3,661

91 new · 95 sold out

Top 10

15.4%

of the value

Est. gain

+$50.98B

on stocks held all quarter

Est. return

+4.9%

on those stocks since Q4 2016

Filed

May 15, 2017

On SEC EDGAR ↗

Positions as of Mar 31, 2017, from State Street's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 28% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2016. Striped tiles are options.

Apple2.8%Microsoft1.9%
Johnson & Johnson1.8%
Exxon Mobil Corp1.6%
Jpmorgan Chase & Co1.3%
Amazon1.3%
Berkshire Hathaway1.2%
Meta1.2%
Lockheed Martin Corp1.1%
Chevron Corp1.1%
Wells Fargo & Co1.0%
Pfizer Inc1.0%
AT&T1.0%
Bank Of America Corp1.0%
United Technologies Corp0.9%
General Electric Co0.9%
Procter & Gamble Co0.9%
Alphabet0.9%Alphabet0.9%IBM0.8%
3m Co0.8%
Verizon Communications Inc0.7%
Home Depot Inc0.7%
Merck & Co0.7%

Largest buys

Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Exxon Mobil Corp~$1.29BAdded · 1.7% → 1.6%+15,740,895 shares
  2. Johnson & Johnson~$829.1MAdded · 1.7% → 1.8%+6,656,371 shares
  3. Ggp Inc~$762.7MNew · 0.0% → 0.1%+32,901,207 shares
  4. Technipfmc Plc~$665.3MNew · 0.0% → 0.1%+20,471,445 shares
  5. Abbott Laboratories~$568.7MAdded · 0.2% → 0.3%+12,806,535 shares
  6. Incyte Corp~$532.4MAdded · 0.0% → 0.1%+3,983,207 shares
  7. Hormel Foods Corp~$503.2MAdded · 0.1% → 0.1%+14,529,149 shares
  8. Enbridge Inc~$478.5MNew · 0.0% → 0.0%+11,436,560 shares
  9. Ishares Msci Eafe ETF~$371.4MAdded · 0.0% → 0.1%+5,962,981 shares
  10. Dish Network Corp~$321.2MAdded · 0.0% → 0.1%+5,059,383 shares

Largest sells

Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Spectra Energy Corp~$1.54BSold out · 0.1% → 0.0%−37,516,908 shares
  2. St Jude Medical Inc~$944.6MSold out · 0.1% → 0.0%−11,779,818 shares
  3. General Growth Pptys Inc~$822.8MSold out · 0.1% → 0.0%−32,939,134 shares
  4. Linear Technology Corp~$762.2MSold out · 0.1% → 0.0%−12,224,134 shares
  5. Fmc Technologies Inc~$491.2MSold out · 0.0% → 0.0%−13,823,443 shares
  6. Allergan Plc~$458.9MCut · 0.4% → 0.3%−1,920,928 shares
  7. Becton Dickinson & Co~$385.8MCut · 0.2% → 0.2%−2,103,178 shares
  8. Hcp Inc~$379.4MCut · 0.1% → 0.1%−12,128,597 shares
  9. Citigroup Inc~$371.6MCut · 0.7% → 0.7%−6,212,367 shares
  10. Pioneer Natural Resources Co~$343.4MCut · 0.2% → 0.2%−1,844,098 shares

Holdings

As of Mar 31, 2017. Changes are in shares against Dec 31, 2016, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
AppleCommon equity shares · shares +0.02% · price +24.0%2.8%$31.57B+$6.12B
MicrosoftCommon equity shares · shares +0.8% · price +6.0%1.9%$20.99B+$1.18B
Johnson & JohnsonCommon equity shares · shares +4.3% · price +8.1%1.8%$19.96B+$1.43B
Exxon Mobil CorpCommon equity shares · shares +7.9% · price −9.1%1.6%$17.70B−$1.65B
Jpmorgan Chase & CoCommon equity shares · shares +0.8% · price +1.8%1.3%$14.98B+$262.2M
AmazonCommon equity shares · shares +1.1% · price +18.2%1.3%$14.67B+$2.24B
Berkshire HathawayCommon equity shares · shares +1.7% · price +2.3%1.2%$13.77B+$300.5M
MetaCommon equity shares · shares +1.7% · price +23.5%1.2%$13.26B+$2.48B
Lockheed Martin CorpCommon equity shares · shares −1.5% · price +7.1%1.1%$12.81B+$845.5M
Chevron CorpCommon equity shares · shares +1.1% · price −8.8%1.1%$12.75B−$1.21B
Wells Fargo & CoCommon equity shares · shares −1.5% · price +1.0%1.0%$11.59B+$114.6M
Pfizer IncCommon equity shares · shares −0.3% · price +5.3%0.98%$10.94B+$553.2M
AT&TCommon equity shares · shares −2.6% · price −2.3%0.96%$10.77B−$254.1M
Bank Of America CorpCommon equity shares · shares −1.8% · price +6.7%0.96%$10.75B+$679.2M
United Technologies CorpCommon equity shares · shares −1.2% · price +2.4%0.94%$10.58B+$244.1M
General Electric CoCommon equity shares · shares −1.0% · price −5.7%0.94%$10.55B−$637.4M
Procter & Gamble CoCommon equity shares · shares −1.5% · price +6.9%0.93%$10.42B+$669.5M
AlphabetCommon equity shares · shares +1.2% · price +7.0%0.90%$10.13B+$653.4M
AlphabetCommon equity shares · shares +0.3% · price +7.5%0.89%$10.01B+$694.7M
IBMCommon equity shares · shares +0.4% · price +4.9%0.80%$8.92B+$415.8M
3m CoCommon equity shares · shares −0.1% · price +7.1%0.78%$8.75B+$583.8M
Verizon Communications IncCommon equity shares · shares +1.2% · price −8.7%0.73%$8.20B−$768.8M
Home Depot IncCommon equity shares · shares +0.7% · price +9.5%0.73%$8.19B+$705.7M
Merck & CoCommon equity shares · shares −1.7% · price +7.9%0.70%$7.82B+$572.9M
Walt Disney Company (The)Common equity shares · shares +0.7% · price +8.8%0.69%$7.68B+$615.4M
Total · 3,661 positions100%$1.12T+$50.98B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2016 to Q1 2017: 3,569 stocks held throughout, up $50.98B (+4.9%).

  1. Apple+$6.12B+24%
  2. Meta+$2.48B+23%
  3. Amazon+$2.24B+18%
  4. Johnson & Johnson+$1.43B+8%
  5. Philip Morris International+$1.26B+23%
  6. General Electric Co−$637.4M−6%
  7. Verizon Communications Inc−$768.8M−9%
  8. Target Corp−$871.9M−24%
  9. Chevron Corp−$1.21B−9%
  10. Exxon Mobil Corp−$1.65B−9%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$4.00T$2.00T$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$3.38T+17%SEC ↗
Q1 2026$2.90T−3%SEC ↗
Q4 2025$2.98T+3%SEC ↗
Q3 2025$2.88T+8%SEC ↗
Q2 2025$2.67T+10%SEC ↗
Q1 2025$2.43T−4%SEC ↗
Q4 2024$2.53T+3%SEC ↗
Q3 2024$2.46T+7%SEC ↗
Q2 2024$2.29T+2%SEC ↗
Q1 2024$2.24T+9%SEC ↗
Q4 2023$2.06T+14%SEC ↗
Q3 2023$1.80T−5%SEC ↗
Q2 2023$1.90T+7%SEC ↗
Q1 2023$1.77T+4%SEC ↗
Q4 2022$1.70T+8%SEC ↗
Q3 2022$1.58T−5%SEC ↗
Q2 2022$1.67T−17%SEC ↗
Q1 2022$2.02T−4%SEC ↗
Q4 2021$2.11T+11%SEC ↗
Q3 2021$1.89T−0%SEC ↗
Q2 2021$1.90T+9%SEC ↗
Q1 2021$1.74T+7%SEC ↗
Q4 2020$1.63T+12%SEC ↗
Q3 2020$1.46T+6%SEC ↗
Q2 2020$1.38T+20%SEC ↗
Q1 2020$1.14T−22%SEC ↗
Q4 2019$1.46T+9%SEC ↗
Q3 2019$1.34T+0%SEC ↗
Q2 2019$1.34T+5%SEC ↗
Q1 2019$1.28T+17%SEC ↗
Q4 2018$1.10T−16%SEC ↗
Q3 2018$1.30T+9%SEC ↗
Q2 2018$1.20T+2%SEC ↗
Q1 2018$1.18T−5%SEC ↗
Q4 2017$1.24T+7%SEC ↗
Q3 2017$1.16T+3%SEC ↗
Q2 2017$1.13T+1%SEC ↗
Q1 2017$1.12T+5%SEC ↗
Q4 2016$1.06T+7%SEC ↗
Q3 2016$992.21B+7%SEC ↗
Q2 2016$930.88B+1%SEC ↗
Q1 2016$924.92BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.